BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9535178)

  • 1. Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs.
    Buczko W; Cierniewski C; Kobylańska A; Koziołkiewicz M; Okruszek A; Pawłowska Z; Pluskota E; Stec WJ
    Pharmacol Ther; 1997; 76(1-3):161-75. PubMed ID: 9535178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereodependent inhibition of plasminogen activator inhibitor type 1 by phosphorothioate oligonucleotides: proof of sequence specificity in cell culture and in vivo rat experiments.
    Stec WJ; Cierniewski CS; Okruszek A; Kobylańska A; Pawłowska Z; Koziołkiewicz M; Pluskota E; Maciaszek A; Rebowska B; Stasiak M
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):567-73. PubMed ID: 9450914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
    Pawlowska Z; Pluskota E; Chabielska E; Buczko W; Okruszek A; Stec WJ; Cierniewski CS
    Thromb Haemost; 1998 Feb; 79(2):348-53. PubMed ID: 9493589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cells.
    Sawa H; Sobel BE; Fujii S
    J Biol Chem; 1994 May; 269(19):14149-52. PubMed ID: 8188696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of plasminogen activator inhibitor release in endothelial cell cultures by antisense oligodeoxyribonucleotides with a 5'-end lipophilic modification.
    Kobylańska A; Pluskota E; Swiatkowska M; Wójcik M; Cierniewska-Cieślak A; Krakowiak A; Boczkowska M; Pawłowska Z; Okruszek A; Koziołkiewicz M; Cierniewski CS; Stec WJ
    Acta Biochim Pol; 1999; 46(3):679-91. PubMed ID: 10698276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells.
    Cierniewski CS; Babinska A; Swiatkowska M; Wilczynska M; Okruszek A; Stec WJ
    Eur J Biochem; 1995 Jan; 227(1-2):494-9. PubMed ID: 7851428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution of a menthyl-conjugated oligodeoxyribonucleotide antisense to PAI-1 mRNA.
    Szemraj J; Al-Nedawi KN; Chabielska E; Buczko W; Pawlowska Z
    Acta Biochim Pol; 2005; 52(4):849-55. PubMed ID: 16302028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and screening of antisense oligodeoxynucleotides against PAI-1 mRNA in endothelial cells in vitro.
    Jiang QS; Wang SQ
    Acta Pharmacol Sin; 2006 Aug; 27(8):1018-23. PubMed ID: 16867253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system.
    Bouchie JL; Hansen H; Feener EP
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1771-9. PubMed ID: 9812917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
    Peng Ho S; Livanov V; Zhang W; Li J; Lesher T
    Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II regulation of plasminogen activator inhibitor-1 gene expression in neurons of normotensive and spontaneously hypertensive rat brains.
    Yu K; Lu D; Paddy MR; Lenk SE; Raizada MK
    Endocrinology; 1996 Jun; 137(6):2503-13. PubMed ID: 8641204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.
    Bhan P; Bhan A; Hong M; Hartwell JG; Saunders JM; Hoke GD
    Nucleic Acids Res; 1997 Aug; 25(16):3310-7. PubMed ID: 9241246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.